
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely used for weight management. It helps reduce appetite, slow gastric emptying, and promote sustainable weight loss when combined with lifestyle modifications.
Concentration
2.5-5 mg/mL
Duration
Approx. 4-20+ weeks depending on vial size and titration
Key Benefits
Related Peptides
Peptide TherapyAOD-9604
Weight management peptide focused on fat metabolism support
$295+
Peptide TherapyMOTS-c
Metabolic efficiency and energy utilization peptide
$325+
Peptide Therapy5-Amino-1MQ
Metabolic support peptide for body composition and wellness optimization
$165+
Peptide TherapyRetatrutide
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. By engaging three metabolic pathways, it represents the next generation of weight management therapies with the potential for greater efficacy in both weight loss and metabolic improvement.
$249+
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.